Pandemic Darlings The pandemic economy, in original documents
Home Source documents Senate Commerce Committee Statement to Senate, No. 2886 — State of New Jersey (February 10, 2025)

Senate Commerce Committee Statement to Senate, No. 2886 — State of New Jersey (February 10, 2025)

Summary

A Senate Commerce Committee statement to the Senate on Senate Bill No. 2886, State of New Jersey, dated February 10, 2025, reporting the bill favorably with committee amendments. As amended, the bill requires a pharmacy practice site to display a notice on its website about insulin manufacturer assistance programs, with the details drafted by the Department of Health. A pharmacy must also provide, on an individual's request, a pamphlet created by the department about those programs, and insulin manufacturers may ask to be included in the notices and pamphlets. The bill takes effect twelve months from the date it is signed into law.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Senate Commerce Committee Statement to Senate, No. 2886 — State of New Jersey (February 10, 2025).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/s2886-scm-statement-2-10-2025-91f437eac7/, SHA-256 a365b98675d8fb9d8600f005cdbce58312aa7c1a6b12039e5e56bed74c61ae34.

Full text

SENATE COMMERCE COMMITTEE

STATEMENT TO

SENATE, No.
2886

with
committee amendments

STATE
OF NEW JERSEY

DATED: FEBRUARY
10, 2025

The Senate Commerce Committee reports favorably and
with committee amendments Senate Bill No. 2886.

This
bill requires pharmacies to provide certain information regarding insulin
manufacturer assistance programs.

As
amended, under this bill, a pharmacy practice site will be required to display,
in a conspicuous manner, a notice on its website, concerning insulin
manufacturer assistance programs at all points of sale, the details of which
are to be drafted by the Department of Health. A pharmacy practice site is also
required to provide, upon the request of an individual, a pamphlet created by
the department concerning insulin manufacturer assistance programs. Insulin
manufacturers offering an assistance program may inform the department of their
intention to be included in the notices and pamphlets. The effective date of
the bill is twelve months from the date it is signed into law.

COMMITTEE AMENDMENTS :

The committee amended the bill to:

(1) require a pharmacy to display, in a conspicuous
manner, information about insulin assistance programs on the website of the
pharmacy and have the Department of Health draft the information to include on
the website;

(2) make the distribution of pamphlets on insulin
assistance programs by request of an individual to the pharmacy; and

(3) alter the effective date to twelve months from
the date it is signed.

File and source

File
2025-02-10_SCM_S2886_S1.htm
Size
6,784 bytes
SHA-256
a365b98675d8fb9d8600f005cdbce58312aa7c1a6b12039e5e56bed74c61ae34
Our copy
2025-02-10_SCM_S2886_S1.htm
Original
No public link identified.
Back to top